Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3430 | 1986 | 41.0 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
206 | 3 | JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION//DENGUE//WEST NILE VIRUS | 52352 |
1069 | 2 | HANTAVIRUS//EBOLA VIRUS//FILOVIRUS | 9951 |
3430 | 1 | ARENAVIRUS//JUNIN VIRUS//LYMPHOCYTIC CHORIOMENINGITIS VIRUS | 1986 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ARENAVIRUS | authKW | 1977694 | 8% | 79% | 162 |
2 | JUNIN VIRUS | authKW | 733064 | 3% | 81% | 59 |
3 | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | authKW | 549558 | 4% | 50% | 72 |
4 | LASSA VIRUS | authKW | 522141 | 2% | 77% | 44 |
5 | LASSA FEVER | authKW | 507581 | 2% | 77% | 43 |
6 | ARENAVIRIDAE | authKW | 432377 | 2% | 94% | 30 |
7 | ARGENTINE HEMORRHAGIC FEVER | authKW | 236507 | 1% | 77% | 20 |
8 | MONTANA BIOTECHNOL | address | 180849 | 1% | 59% | 20 |
9 | VIRAL HEMORRHAGIC FEVER | authKW | 140997 | 2% | 27% | 34 |
10 | LASSA FEVER VIRUS | authKW | 118253 | 1% | 77% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Virology | 81957 | 49% | 1% | 966 |
2 | Immunology | 5163 | 25% | 0% | 505 |
3 | Tropical Medicine | 2220 | 5% | 0% | 103 |
4 | Microbiology | 1255 | 12% | 0% | 233 |
5 | Infectious Diseases | 1084 | 8% | 0% | 152 |
6 | Parasitiology | 337 | 3% | 0% | 56 |
7 | Public, Environmental & Occupational Health | 184 | 5% | 0% | 106 |
8 | Biotechnology & Applied Microbiology | 133 | 5% | 0% | 99 |
9 | Medicine, General & Internal | 86 | 5% | 0% | 96 |
10 | Medicine, Research & Experimental | 82 | 4% | 0% | 72 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MONTANA BIOTECHNOL | 180849 | 1% | 59% | 20 |
2 | IMMUNOL MICROBIAL SCI | 93919 | 4% | 8% | 79 |
3 | IMMUNOL MICROBIAL SCI IMM 6 | 76868 | 0% | 100% | 5 |
4 | LASSA FEVER CONTROL | 75326 | 0% | 70% | 7 |
5 | SPECIAL PATHOGENS BRANCH | 54967 | 1% | 12% | 29 |
6 | IMM 6 | 49194 | 0% | 80% | 4 |
7 | PL DIAGNOST BRANCH | 46121 | 0% | 100% | 3 |
8 | VIRAL IMMUNOBIOL | 44050 | 1% | 16% | 18 |
9 | LASSA FEVER | 40993 | 0% | 67% | 4 |
10 | UNITE BIOL INFECT VIRALES EMERGENTES | 39562 | 1% | 23% | 11 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF VIROLOGY | 33913 | 15% | 1% | 296 |
2 | VOPROSY VIRUSOLOGII | 18407 | 3% | 2% | 52 |
3 | MEDICAL MICROBIOLOGY AND IMMUNOLOGY | 17284 | 2% | 3% | 39 |
4 | VIROLOGY | 12603 | 6% | 1% | 124 |
5 | MEDICINA-BUENOS AIRES | 10016 | 2% | 1% | 44 |
6 | INTERVIROLOGY | 8855 | 2% | 2% | 33 |
7 | CURRENT TOPICS IN MICROBIOLOGY AND IMMUNOLOGY | 8639 | 2% | 1% | 44 |
8 | JOURNAL OF MEDICAL VIROLOGY | 6034 | 3% | 1% | 55 |
9 | JOURNAL OF GENERAL VIROLOGY | 5705 | 4% | 1% | 71 |
10 | ANTIVIRAL RESEARCH | 5696 | 2% | 1% | 36 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ARENAVIRUS | 1977694 | 8% | 79% | 162 | Search ARENAVIRUS | Search ARENAVIRUS |
2 | JUNIN VIRUS | 733064 | 3% | 81% | 59 | Search JUNIN+VIRUS | Search JUNIN+VIRUS |
3 | LYMPHOCYTIC CHORIOMENINGITIS VIRUS | 549558 | 4% | 50% | 72 | Search LYMPHOCYTIC+CHORIOMENINGITIS+VIRUS | Search LYMPHOCYTIC+CHORIOMENINGITIS+VIRUS |
4 | LASSA VIRUS | 522141 | 2% | 77% | 44 | Search LASSA+VIRUS | Search LASSA+VIRUS |
5 | LASSA FEVER | 507581 | 2% | 77% | 43 | Search LASSA+FEVER | Search LASSA+FEVER |
6 | ARENAVIRIDAE | 432377 | 2% | 94% | 30 | Search ARENAVIRIDAE | Search ARENAVIRIDAE |
7 | ARGENTINE HEMORRHAGIC FEVER | 236507 | 1% | 77% | 20 | Search ARGENTINE+HEMORRHAGIC+FEVER | Search ARGENTINE+HEMORRHAGIC+FEVER |
8 | VIRAL HEMORRHAGIC FEVER | 140997 | 2% | 27% | 34 | Search VIRAL+HEMORRHAGIC+FEVER | Search VIRAL+HEMORRHAGIC+FEVER |
9 | LASSA FEVER VIRUS | 118253 | 1% | 77% | 10 | Search LASSA+FEVER+VIRUS | Search LASSA+FEVER+VIRUS |
10 | WHITEWATER ARROYO VIRUS | 107615 | 0% | 100% | 7 | Search WHITEWATER+ARROYO+VIRUS | Search WHITEWATER+ARROYO+VIRUS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GUNTHER, S , LENZ, O , (2004) LASSA VIRUS.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 41. ISSUE 4. P. 339-390 | 229 | 86% | 75 |
2 | GRANDE-PEREZ, A , MARTIN, V , MORENO, H , DE LA TORRE, JC , (2016) ARENAVIRUS QUASISPECIES AND THEIR BIOLOGICAL IMPLICATIONS.QUASISPECIES: FROM THEORY TO EXPERIMENTAL SYSTEMS. VOL. 392. ISSUE . P. 231 -275 | 171 | 66% | 1 |
3 | RADOSHITZKY, SR , KUHN, JH , DE KOK-MERCADO, F , JAHRLING, PB , BAVARI, S , (2012) DRUG DISCOVERY TECHNOLOGIES AND STRATEGIES FOR MACHUPO VIRUS AND OTHER NEW WORLD ARENAVIRUSES.EXPERT OPINION ON DRUG DISCOVERY. VOL. 7. ISSUE 7. P. 613-632 | 146 | 83% | 6 |
4 | LUKASHEVICH, IS , SALVATO, MS , (2006) LASSA VIRUS GENOME.CURRENT GENOMICS. VOL. 7. ISSUE 6. P. 351 -379 | 155 | 88% | 1 |
5 | MCLAY, L , ANSARI, A , LIANG, YY , LY, H , (2013) TARGETING VIRULENCE MECHANISMS FOR THE PREVENTION AND THERAPY OF ARENAVIRAL HEMORRHAGIC FEVER.ANTIVIRAL RESEARCH. VOL. 97. ISSUE 2. P. 81 -92 | 118 | 88% | 4 |
6 | WANG, W , ZHOU, Z , ZHANG, LK , WANG, SB , XIAO, GF , (2016) STRUCTURE-FUNCTION RELATIONSHIP OF THE MAMMARENAVIRUS ENVELOPE GLYCOPROTEIN.VIROLOGICA SINICA. VOL. 31. ISSUE 5. P. 380 -394 | 105 | 87% | 0 |
7 | LUKASHEVICH, IS , (2012) ADVANCED VACCINE CANDIDATES FOR LASSA FEVER.VIRUSES-BASEL. VOL. 4. ISSUE 11. P. 2514 -2557 | 127 | 73% | 13 |
8 | MORAZ, ML , KUNZ, S , (2011) PATHOGENESIS OF ARENAVIRUS HEMORRHAGIC FEVERS.EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. VOL. 9. ISSUE 1. P. 49 -59 | 94 | 94% | 32 |
9 | GRANT, A , SEREGIN, A , HUANG, C , KOLOKOLTSOVA, O , BRASIER, A , PETERS, C , PAESSLER, S , (2012) JUNIN VIRUS PATHOGENESIS AND VIRUS REPLICATION.VIRUSES-BASEL. VOL. 4. ISSUE 10. P. 2317-2339 | 91 | 95% | 19 |
10 | LUKASHEVICH, IS , PUSHKO, P , (2016) VACCINE PLATFORMS TO CONTROL LASSA FEVER.EXPERT REVIEW OF VACCINES. VOL. 15. ISSUE 9. P. 1135 -1150 | 102 | 84% | 0 |
Classes with closest relation at Level 1 |